Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMSF10P)

Drug Name
RGN-259 Drug Info
Indication
Disease Entry ICD 11 Status REF
Vaginal infection GA02.0 Phase 2 [1]
Cross-matching ID
PubChem CID
155387671
TTD Drug ID
DMSF10P

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Actin (ACT) TTH5WZF NOUNIPROTAC Modulator [2]

References

1 Clinical pipeline report, company report or official report of Regulus Therapeutics.
2 Thymosin beta4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial. Cornea. 2015 May;34(5):491-6.